SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

ResMed to buy back $450 million in stock under ASR

ResMed will buy back $450 million of stock under an accelerated share repurchase agreement with Citibank, using a 20 million-share repurchase authorization from 2014.

RMD
SquawkNews Desk

ResMed said it will buy back $450 million of its stock under an accelerated share repurchase agreement with Citibank. The repurchases will be made under a 20 million-share authorization from 2014, according to a Tuesday regulatory filing by the medical equipment company.

Related stories

Analysts Adjust Datadog Price Targets After Q3 Results Goldman Sachs raised its target to $171 from $158. Macquarie, RBC, Bernstein and JPMorgan also adjusted targets; the consensus rating remains Buy. M impact | EQUITY | Nov 06, 2026, 03:02 AM UTC Wheaton Precious Metals Reports Q3 2026 Results, Maintains Guidance Wheaton reported adjusted earnings of $0.90 per share and revenue of $771.7 million. It maintained 2026 production guidance of 400,000–430,000 ounces of gold and 27–29 million ounc M impact | EQUITY | Nov 06, 2026, 03:02 AM UTC OUTFRONT Media Reports Quarterly Results for Period Ended September 30 The headline reports quarterly results, but the supplied body contains no figures or further result details. M impact | EQUITY | Nov 06, 2026, 03:02 AM UTC Asian session market picture: S&P 500 +0.42%, Nasdaq 100 +1.47%; USD/JPY +0.14%, WTI +1.15%, 1810 leads volume Asian session market picture. US index futures: S and P futures is up 0.42 percent, Nasdaq futures is up 1.47 percent, Dow futures is down 0.49 percent and Russell futures is up 0. M impact | EQUITY | Nov 06, 2026, 03:01 AM UTC HA Sustainable Infrastructure Capital Reports Quarterly Results The company reported results for the quarter ended September 30. The supplied text contains no figures. M impact | EQUITY | Nov 06, 2026, 02:55 AM UTC Nikkei Stock Average Falls to 56745.81, Lowest Since April 13 M impact | EQUITY | Nov 06, 2026, 02:46 AM UTC